Finding Common Regulatory Ground in AIs Growing Role within Pharmacovigilance | By: Anuradha (Annie) Prabhakar, Associate Director, Product Management, Vigilance Detect, IQVIA

Pharmacovigilance has traditionally required organizations to balance the urgency of reporting with the rigor of accurately detecting adverse event and product complaints. AI has the potential to ease this burden by enabling earlier pre‑signal identification, automated detection, faster case processing and expanded surveillance across both structured and unstructured data